BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Pharm Country

  Merck Consumer Care Release: OXYTROL® FOR WOMEN, the First Over-the-Counter Treatment for Overactive Bladder in Women, Now Available Nationwide

  September 25, 2013

   · 

  6 min read
• Deals

  Foundation Medicine, Inc. Lands $106 Million in Upsized IPO

  September 25, 2013

   · 

  1 min read
• Oramed Pharmaceuticals Inc. to Participate in Barclays’ Israel Biotech Corporate Day in Zurich on September 30, 2013

  September 25, 2013

   · 

  1 min read
• Job Trends

  No Sales Force Expansion for Eli Lilly and Company as Focus Shifts to Grabbing a Bigger Slice of U.S.'s Diabetes Market

  September 25, 2013

   · 

  1 min read
• Deals

  Ophthotech Corporation Reels in $167 Million in IPO

  September 25, 2013

   · 

  1 min read
• Business

  Pacific Biosciences Strikes $75 Million Deal With Roche Diagnostics Corporation

  September 25, 2013

   · 

  1 min read
• BioMidwest

  FDA Asks for More Info on EnteroMedics’ Weight Loss Implant

  September 25, 2013

   · 

  1 min read
• FDA

  Illumina, Inc. Applies CE Mark to Expanded MiSeqDx™ System

  September 25, 2013

   · 

  2 min read
• Pharm Country

  Champions Oncology, Inc. to Present at the Aegis Capital Corp. 2013 Healthcare Conference

  September 25, 2013

   · 

  1 min read
• Drug Development

  Cornerstone Pharmaceuticals, Inc. Initiates Phase 2 Clinical Trial of CPI-613 for the Treatment of Myelodysplastic Syndrome

  September 25, 2013

   · 

  1 min read